Eculizumab in post-transplant C3 glomerulonephritis caused by a C3 mutation .
In this report, we describe the successful use of eculizumab to treat a patient with recurrent post-transplant C3GN caused by a C3 gene gain-of-function mutation, and also review the published literature regarding the use of eculizumab for the treatment of recurrent C3 glomerulopathy.
.
PMID: 31661064 [PubMed - as supplied by publisher]
Source: Clinical Nephrology - Category: Urology & Nephrology Authors: Kim JS, Foster KW, Westphal SG Tags: Clin Nephrol Source Type: research
More News: Genetics | Glomerulonephritis | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology